Specifically, we identified GAS2, a candidate oncogene, as a new example of gene the hypomethylation of which is associated with robust overexpression in CP‐CML cells. This evidence concerns the gene GAS2 and chronic myelogenous leukemia, BCR-ABL1 positive.